182 related articles for article (PubMed ID: 977399)
1. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
Fowler JF; Sheldon PW; Denekamp J; Field SB
Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
[No Abstract] [Full Text] [Related]
2. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
Denekamp J; Harris SR
Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
[No Abstract] [Full Text] [Related]
3. The response of a transplantable tumor to fractionated irradiation. II. Fast neutrons.
Denekamp J; Harris SR; Morris C; Field SB
Radiat Res; 1976 Oct; 68(1):93-103. PubMed ID: 967976
[No Abstract] [Full Text] [Related]
4. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
Denekamp J; Morris C; Field SB
Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
[No Abstract] [Full Text] [Related]
5. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Sheldon PW; Hill SA; Foster JL; Fowler JF
Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
Sheldon PW; Foster JL; Fowler JF
Br J Cancer; 1974 Dec; 30(6):560-5. PubMed ID: 4451633
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Fractionation studies on tumours using X rays and fast neutrons and the modification by electron affinic sensitizers.
Denekamp J
Br J Radiol; 1975 Jul; 48(571):571. PubMed ID: 1148589
[No Abstract] [Full Text] [Related]
8. [Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
Tanaka M; Nakajima T; Fukuda H; Kida A; Tsumura M; Sakashita M; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Dec; 46(12):1442-3. PubMed ID: 3822789
[No Abstract] [Full Text] [Related]
9. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
Denekamp J; Harris SR
Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
[No Abstract] [Full Text] [Related]
10. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
Brown JM
Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
[No Abstract] [Full Text] [Related]
11. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
12. Developments in radiotherapy other than heavy particle beams.
Fowler JF
Int J Radiat Oncol Biol Phys; 1977; 3():351-8. PubMed ID: 207661
[No Abstract] [Full Text] [Related]
13. Metronidazole and fractionated radiotherapy of a murine tumor.
Stone HB
Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1133-7. PubMed ID: 993090
[No Abstract] [Full Text] [Related]
14. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
Brown JM
Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
[No Abstract] [Full Text] [Related]
15. Effect of metronidazole on the radiocurability and oxygenation of the C3HBA tumor.
Haynes MJ; Inch WR
Radiat Res; 1976 Oct; 68(1):184-9. PubMed ID: 967973
[No Abstract] [Full Text] [Related]
16. RBE values for regrowth of C3H mouse mammary carcinomas after single doses of cyclotron neutrons or X-rays.
Fowler JF; Denekamp J; Field SB
Eur J Cancer (1965); 1973; 9(11-12):853-7. PubMed ID: 4804312
[No Abstract] [Full Text] [Related]
17. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
[No Abstract] [Full Text] [Related]
19. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
[No Abstract] [Full Text] [Related]
20. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
